INCY insider buying – Incyte Corp
17 insider purchases since 2016 worth $562.7M by 7 different insiders. Last 12 months: 0 purchases, $0. Most recent filing: 2022-03-10.
Large company Public float $11.2B (latest 10-K, SEC).
Same time range as the chart above - each mark sits under the week of the trade. Circles = purchases (height = price paid, size = amount), red triangles = open-market sales of $50k+. Prices as reported, not adjusted for later stock splits. 13 older purchases (before the 5-year window) are listed in the table below.
Purchases are open-market buys (SEC Form 4, code "P") - insiders paying with their own money. Sales are open-market sales (code "S") of $50,000 or more; many sales are pre-planned (Rule 10b5-1) or made for taxes and diversification. Each row links to the original filing.
Bought, sold, still holding?
| Insider | Bought | First / last buy | Sold since 2016 | Holds now* | Status |
|---|---|---|---|---|---|
| 667, L.P. Director | $210.2M 4× · 2,936,054 sh | 2016-02-12 2022-03-08 | – | 3,411,412 shares as of 2026-04-02 | Holds - never sold |
| BAKER FELIX Director | $178.8M 2× · 2,777,231 sh | 2016-02-11 2022-02-17 | – | 28,799,133 shares as of 2026-07-02 | Holds - never sold |
| BAKER JULIAN Director | $107.0M 1× · 1,598,374 sh | 2022-02-10 2022-02-10 | – | 34,036,299 shares as of 2023-03-15 | Holds - never sold |
| Baker Brothers Life Sciences LP Director | $51.2M 1× · 800,000 sh | 2016-03-15 2016-03-15 | – | 28,780,954 shares as of 2025-07-02 | Holds - never sold |
| BAKER BROS. ADVISORS LP Director | $13.2M 1× · 100,000 sh | 2017-09-08 2017-09-08 | – | 3,428,054 shares as of 2026-06-10 | Holds - never sold |
| Hoppenot Herve CEO | $1.9M 2× · 27,925 sh | 2018-05-02 2021-02-23 | 4× · $50.8M last 2025-11-10 | 326,803 shares as of 2025-12-10 | Sold part |
| BIENAIME JEAN JACQUES Director | $533,435 6× · 4,500 sh | 2017-04-07 2018-11-08 | 2× · $212,888 last 2020-11-10 | 24,424 shares as of 2026-06-10 | Sold part |
* Shares held after the insider's most recent SEC filing for this company (all share classes, direct and indirect). If an insider stops filing, later changes are not known.
Insider buying and selling by year
| Year | Purchases | Bought | Buyers | Sales | Sold |
|---|---|---|---|---|---|
| 2026 | 0 | – | – | 19 | $56.7M |
| 2025 | 0 | – | – | 25 | $36.8M |
| 2024 | 0 | – | – | 12 | $5.5M |
| 2023 | 0 | – | – | 8 | $10.2M |
| 2022 | 3 | $170.8M | 3 | 10 | $8.6M |
| 2021 | 2 | $116.6M | 2 | 10 | $8.5M |
| 2020 | 0 | – | – | 35 | $45.5M |
| 2019 | 0 | – | – | 33 | $31.1M |
| 2018 | 2 | $982,865 | 2 | 10 | $9.4M |
| 2017 | 6 | $13.7M | 2 | 32 | $52.9M |
| 2016 | 4 | $260.7M | 3 | 10 | $15.2M |
Insider purchases
| Filed | Insider | Role | Shares | Avg price | Value | Holdings | Filing |
|---|---|---|---|---|---|---|---|
| 2022-03-10 | 667, L.P. | Director | 389,080 | $72.24 | $28.1M | +1.2% | SEC |
| 2022-02-22 | BAKER FELIX | Director | 525,804 | $67.96 | $35.7M | +1.6% | SEC |
| 2022-02-14 | BAKER JULIAN | Director | 1,598,374 | $66.91 | $107.0M | +5.2% | SEC |
| 2021-12-17 | 667, L.P. | Director | 1,595,519 | $72.43 | $115.6M | +5.4% | SEC |
| 2021-02-23 | Hoppenot Herve | CEO | 12,925 | $77.37 | $1.0M | +4.8% | SEC |
| 2018-11-09 | BIENAIME JEAN JACQUES | Director | 1,000 | $68.77 | $68,765 | +17.6% | SEC |
| 2018-05-03 | Hoppenot Herve | CEO | 15,000 | $60.94 | $914,100 | +5.7% | SEC |
| 2017-09-08 | BAKER BROS. ADVISORS LP | Director | 100,000 | $132.00 | $13.2M | +0.3% | SEC |
| 2017-06-02 | BIENAIME JEAN JACQUES | Director | 500 | $131.80 | $65,900 | +12.0% | SEC |
| 2017-05-17 | BIENAIME JEAN JACQUES | Director | 500 | $115.00 | $57,500 | +13.6% | SEC |
| 2017-05-02 | BIENAIME JEAN JACQUES | Director | 500 | $124.26 | $62,130 | +15.7% | SEC |
| 2017-04-17 | BIENAIME JEAN JACQUES | Director | 1,000 | $139.66 | $139,660 | +45.9% | SEC |
| 2017-04-11 | BIENAIME JEAN JACQUES | Director | 1,000 | $139.48 | $139,480 | +85.0% | SEC |
| 2016-03-17 | Baker Brothers Life Sciences LP | Director | 800,000 | $63.98 | $51.2M | +4.2% | SEC |
| 2016-02-26 | 667, L.P. | Director | 64,290 | $70.79 | $4.6M | +0.3% | SEC |
| 2016-02-16 | 667, L.P. | Director | 887,165 | $69.86 | $62.0M | +4.9% | SEC |
| 2016-02-16 | BAKER FELIX | Director | 2,251,427 | $63.53 | $143.0M | +14.2% | SEC |
Insider sales
| Filed | Insider | Role | Shares | Avg price | Value | Type | Filing |
|---|---|---|---|---|---|---|---|
| 2026-11-10 | Stein Steven H | CMO & Head of Late-Stage Dev. | -240,193 | $118.39 | $28.4M | Pre-planned (10b5-1) | SEC |
| 2026-09-17 | CAGNONI PABLO J | CEO | 23,218 | $120.49 | $2.8M | Pre-planned (10b5-1) | SEC |
| 2026-08-20 | CAGNONI PABLO J | CEO | 10,801 | $125.56 | $1.4M | Pre-planned (10b5-1) | SEC |
| 2026-08-14 | CAGNONI PABLO J | CEO | 10,803 | $120.04 | $1.3M | Pre-planned (10b5-1) | SEC |
| 2026-08-07 | Mayes Patrick A | Officer | 2,207 | $123.99 | $273,646 | Pre-planned (10b5-1) | SEC |
| 2026-08-07 | CAGNONI PABLO J | CEO | 10,640 | $122.69 | $1.3M | Pre-planned (10b5-1) | SEC |
| 2026-08-04 | Mayes Patrick A | Officer | 47,954 | $119.58 | $5.7M | Pre-planned (10b5-1) | SEC |
| 2026-08-04 | CAGNONI PABLO J | CEO | 15,888 | $119.70 | $1.9M | Pre-planned (10b5-1) | SEC |
| 2026-07-20 | Stein Steven H | Officer | 1,877 | $114.73 | $215,348 | Pre-planned (10b5-1) | SEC |
| 2026-07-20 | Issa Mohamed Khairie | Officer | 1,093 | $115.01 | $125,706 | Pre-planned (10b5-1) | SEC |
| 2026-07-16 | Stein Steven H | Officer | 28,237 | $113.05 | $3.2M | Pre-planned (10b5-1) | SEC |
| 2026-06-08 | Tray Thomas | Officer | 2,639 | $100.00 | $263,900 | Pre-planned (10b5-1) | SEC |
| 2026-05-28 | Tray Thomas | Officer | 2,051 | $97.35 | $199,665 | Pre-planned (10b5-1) | SEC |
| 2026-05-21 | Clancy Paul J | Director | 15,000 | $94.93 | $1.4M | Pre-planned (10b5-1) | SEC |
| 2026-04-21 | CAGNONI PABLO J | CEO | 18,667 | $96.50 | $1.8M | Pre-planned (10b5-1) | SEC |
Showing the latest 15 of 204 sales of $50,000+ since 2016.
Compiled automatically from public SEC filings. Not investment advice. Get every new insider purchase in the daily report.
Get every new insider purchase the day it's filed
Daily report with all SEC insider buys, cluster buys, company events and the crypto money-flow radar.
Get started free